The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients

British Journal of Cancer

Volumn 97, Issue 5, 2007, Pages 605-611

  Chan, J K ^a   Kapp, D S ^b   Cheung, M K ^b   Osann, K ^c   Shin, J Y ^b   Cohn, D ^d   Seid, P L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Positive lymph nodes; Prognostic factors; Uterine cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; UTERINE NEOPLASMS;

EID: 34548354743     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603898     Document Type: Article

References (42)

1. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9: 775-784
2. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23: 8706-8712
3. Blythe JG, Edwards E, Heimbecker P (1997) Paraaortic lymph node biopsy: a twenty-year study. Am J Obstet Gynecol 176: 1157-1162;discussion 1162-5
4. Bruner DW, Barsevick A, Tian C, Randall M, Mannel R, Cohn DE, Sorosky J, Spirtos NM (2006) Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. Qual Life Res 16: 89-100
5. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12 333 patients. Cancer 107: 1823-1830
6. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 60: 2035-2041
7. Faught W, Faught F, Fung MFK, Krepart GV, Lotocki RJ, Heywood MS, Genest P (1998) Microscopic surgical stage IIIc endometrioid adenocarcinoma of the endometrium: implications for bimodal adjuvant therapy. Int J Gynecol Cancer 8: 41-45
8. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL (2003) Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21: 1029-1034
9. Greven KM, Lanciano RM, Corn B, Case D, Randall ME (1993) Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence. Cancer 71: 3697-3702
10. Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, Vicini FA (2003) Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 56: 658-670
11. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167: 1295-1298
12. Homesley HD et al. (2000) GOG Protocol no #184. A randomized Phase III study of tumor volume directed pelvic plus or minus para-aortic irradiation followed by cisplatin doxorubicin or cisplatin doxorubicin paclitaxel for advanced endometrial carcinoma
13. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130
14. Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, Catalano PJ, Haller DG (2003) Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10: 213-218
15. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin III F, Conner W (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56: 29-33
16. Larson DM, Copeland LJ, Gallager HS, Wharton JT, Gershenson DM, Edwards CL, Malone Jr JM, Rutledge FN (1987) Prognostic factors in stage II endometrial carcinoma. Cancer 60: 1358-1361
17. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21: 2912-2919
18. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS (1991) Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78: 63-69
19. Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102: 92-97
20. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC (2006) Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101: 200-208
21. Mariani A, Webb MJ, Keeney GL, Haddock MG, Aletti G, Podratz KC (2002) Stage IIIC endometrioid corpus cancer includes distinct subgroups. Gynecol Oncol 87: 112-117
22. Mariani A, Webb MJ, Rao SK, Lesnick TG, Podratz KC (2001) Significance of pathologic patterns of pelvic lymph node metastases in endometrial cancer. Gynecol Oncol 80: 113-120
23. McMeekin DS, Lashbrook D, Gold M, Scribner DR, Kamelle S, Tillmanns TD, Mannel R (2001) Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 82: 375-379
24. Moore DH, Stehman FB (1996) What is the appropriate management of early stage cervical cancer (International Federation of Gynecology and Obstetrics stages I and IIA), surgical assessment of lymph nodes, and role of therapeutic resection of lymph nodes involved with cancer? J Natl Cancer Inst Monogr 43-46
25. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 40: 55-65
26. Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K (1999) FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 75: 211-214
27. Nieto Y, Nawaz S, Jones RB, Shpall EJ, Cagnoni PJ, McSweeney PA, Baron A, Razook C, Matthes S, Bearman SI (2002) Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. J Clin Oncol 20: 707-718
28. NCCN (2006) NCCN Clinical Practice Guidelines in Oncology Breast Cancer. V.2.2006
29. Potish RA, Twiggs LB, Adcock LL, Savage JE, Levitt SH, Prem KA (1985) Paraaortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol 65: 251-256
30. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA (2006) Randomized phase III trial of whole-abdominal irradiation vs doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 24: 36-44
31. Rose PG, Cha SD, Tak WK, Fitzgerald T, Reale F, Hunter RE (1992) Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma. Int J Radiat Oncol Biol Phys 24: 229-233
32. Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller Jr AF (1996) The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 63: 34-39
33. Sierzega M, Popiela T, Kulig J, Nowak K (2006) The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 33: 240-245
34. Surveillance, Epidemiology End Results (SEER) Program (2005) (www.seer.cancer.gov) SEER*Stat Database: incidence SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch
35. Tang X, Tanemura K, Ye W, Ohmi K, Tsunematsu R, Yamada T, Katsumata N, Sonoda T (1998) Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer. Jpn J Clin Oncol 28: 673-678
36. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson III AB, Cummings B, Gunderson L, Macdonald JS, Mayer RJ (2001) Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19: 157-163
37. van der Velden J, van Lindert AC, Lammes FB, ten Kate FJ, Sie-Go DM, Oosting H, Heintz AP (1995) Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 75: 2885-2890
38. Vinh-Hung V, Verschraegen C, Promish DI, Cserni G, Van de Steene J, Tai P, Vlastos G, Voordeckers M, Storme G, Royce M (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res 6: R680-R688
39. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N (2005) Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 96: 651-657
40. Weir L, Speers C, D'Yachkova Y, Olivotto IA (2002) Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 20: 1793-1799
41. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, Vlastos G, Wallace AM, Hortobagyi GN, Nieto Y (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24: 2910-2916
42. Yasunaga M, Yamasaki F, Tokunaga O, Iwasaka T (2003) Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis. Int J Gynecol Pathol 22: 341-346